Shree Deepa Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
- Paid Up Capital ₹ 3.75 M
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2009
- Open Charges ₹ 5.97 M
About Shree Deepa Drugs And Pharmaceuticals
Shree Deepa Drugs And Pharmaceuticals Private Limited (SDDAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 November 1994 and has a history of 30 years and two months. Its registered office is in Hyderabad, Telangana.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2009. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 3.75 M.
The company currently has active open charges totaling ₹5.97 M.
Company Details
-
LocationHyderabad, Telangana
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239TG1994PTC018743
-
Company No.
018743
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Nov 1994
-
Date of AGM
30 Sep 2009
-
Date of Balance Sheet
31 Mar 2009
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Shree Deepa Drugs And Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Taraka Pinnamaneni
|
Director | 03-Feb-2010 | Current |
|
Lakshmi Badiga
|
Director | 03-Feb-2010 | Current |
Financial Performance of Shree Deepa Drugs And Pharmaceuticals.
Enhance accessibility to Shree Deepa Drugs And Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Deepa Drugs And Pharmaceuticals?
Unlock access to Shree Deepa Drugs And Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹5.97 M
₹0
Charges Breakdown by Lending Institutions
- The A.P. Mahesh Co.Op. Urban Bank Ltd. : 0.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Feb 2001 | The A.P. Mahesh Co.Op. Urban Bank Ltd. | ₹0.42 M | Open |
| 14 Jun 1997 | The A.P. Mahesh Co.Op. Urban Bank Ltd. | ₹1.35 M | Open |
| 25 Mar 1996 | The A.P. Mahesh Co.Op. Urban Bank Ltd. | ₹4.20 M | Open |
How Many Employees Work at Shree Deepa Drugs And Pharmaceuticals?
Unlock and access historical data on people associated with Shree Deepa Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Deepa Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Deepa Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.